Your browser doesn't support javascript.
loading
Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer.
Hill, Addie; Gong, Jun; Wilczynski, Sharon; Mirza, Rizvan; Erhunmwunsee, Loretta; Salgia, Ravi.
Affiliation
  • Hill A; City of Hope Cancer Center, Duarte, CA.
  • Gong J; City of Hope Cancer Center, Duarte, CA.
  • Wilczynski S; City of Hope Cancer Center, Duarte, CA.
  • Mirza R; City of Hope Cancer Center, Duarte, CA.
  • Erhunmwunsee L; City of Hope Cancer Center, Duarte, CA.
  • Salgia R; City of Hope Cancer Center, Duarte, CA.
J Oncol Pract ; 14(9): 569-571, 2018 09.
Article in En | MEDLINE | ID: mdl-30044685
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Neoadjuvant Therapy / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Lung Neoplasms Limits: Female / Humans / Middle aged Language: En Journal: J Oncol Pract Year: 2018 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Neoadjuvant Therapy / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Lung Neoplasms Limits: Female / Humans / Middle aged Language: En Journal: J Oncol Pract Year: 2018 Document type: Article Affiliation country: